SCHEMBL20356648

SCHEMBL20356648

CCNc1nc(C(=O)O)nc(C)c1Oc1ccc(Cl)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 3/20 0.46
▸ HPGD P15428 3/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ HTT P42858 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ PKM P14618 1/20 0.41
▸ TTR P02766 2/20 0.41
▸ TSHR P16473 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ MAPT P10636 2/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ GPR55 Q9Y2T6 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ MRGPRX4 Q96LA9 3/20 0.39
▸ S1PR4 O95977 1/20 0.39
▸ LPAR2 Q9HBW0 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ CHRM1 P11229 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23927528 0.99 GAA (0.45) GAAHPGDL3MBTL1HTTATM
SCHEMBL23955980 0.90 HPGD (0.45) GAAHPGDL3MBTL1HTTATM
SCHEMBL21526004 0.87 TTR (0.43) GAAHPGDL3MBTL1SMN1; SMN2TTR
SCHEMBL23955981 0.85 HPGD (0.52) GAAHPGDL3MBTL1HTTATM
SCHEMBL21526046 0.82 TTR (0.47) GAAHPGDL3MBTL1HTTTTR
SCHEMBL20356573 0.81 GAA (0.45) GAAHPGDL3MBTL1SMN1; SMN2TTR
SCHEMBL20356753 0.81 TTR (0.42) GAAHPGDL3MBTL1HTTTTR
SCHEMBL20356572 0.79 TTR (0.50) GAAHPGDL3MBTL1TTRTSHR
SCHEMBL21526073 0.76 SMN1; SMN2 (0.44) HPGDL3MBTL1HTTSMN1; SMN2NPSR1
Hydrochloric Acid SCHEMBL21526127 0.76 SMN1; SMN2 (0.43) HPGDL3MBTL1HTTSMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11034659-B2 Pyrimidine derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2021-06-15 — — US disclosed
US-20200172494-A1 PYRIMIDINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2020-06-04 — — US disclosed
EP-3564216-A1 PYRIMIDINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2019-11-06 — — EP disclosed
WO-2018124000-A1 PYRIMIDINE DERIVATIVE 第一三共株式会社 2018-07-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11034659-B2 Pyrimidine derivative GPR39, CFTR, TMEM109 GAA 3739/4885HPGD 2237/4885L3MBTL1 3262/4885
US-20200172494-A1 PYRIMIDINE DERIVATIVE GPR39, CFTR, TMEM109 GAA 3739/4885HPGD 2237/4885L3MBTL1 3262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback